|
New research reveals that product attributes are key to designing a post-generic strategy.
Nov 1, 2004
By:
Andrew Parece, MBA, Edward Tuttle, Anne Hector
Sometimes the loss of revenue from a branded drug can outweigh the royalty stream from an authorized generic.
|
|